Dr Siba Prasad Raychaudhuri, MD | |
510 Ashton Ave, Palo Alto, CA 94306-3607 | |
(650) 424-9147 | |
Not Available |
Full Name | Dr Siba Prasad Raychaudhuri |
---|---|
Gender | Male |
Speciality | Rheumatology |
Experience | 41 Years |
Location | 510 Ashton Ave, Palo Alto, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821033275 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | A52869 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of California Davis Medical Center | Sacramento, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Regents Of The Univ Of Ca | 3375456619 | 1346 |
News Archive
Officials announced Monday that the government will not enforce the mandate for businesses with 50 to 99 workers until 2016. In addition, larger employers will also be allowed to cover just 70 percent of workers in 2015, instead of the 90 percent originally required.
The Endocrine Society, representing more than 14,000 physicians and scientists in the field of endocrinology, strongly opposes the Medicare Payment Advisory Commission's (MedPAC) recommendation to reduce payments for specialists by 17.7 percent to partially fund the elimination of the sustainable growth rate (SGR) formula.
Researchers at the Mayo Clinic found they could isolate and culture nanoparticles from filtered homogenates of diseased calcified human cardiovascular tissue. These cultured nano-sized particles were recognized by a DNA-specific dye, incorporated radiolabeled uridine, and after decalcification, appeared via electron microscopy to contain cell walls.
Although drug therapy is the accepted first-line treatment for panic disorders, 17% to 64% of patients do not respond adequately and continue to exhibit one of the most common symptoms of PD, the panic attack.
A new tool for neuroscientists delivers a thousand pinpricks of light to a chunk of gray matter smaller than a sugar cube. The new fiber-optic device, created by biologists and engineers at the Massachusetts Institute of Technology (MIT) in Cambridge, is the first tool that can deliver precise points of light to a 3-D section of living brain tissue. The work is a step forward for a relatively new but promising technique that uses gene therapy to turn individual brain cells on and off with light.
› Verified 2 days ago
Entity Name | Regents Of The Univ Of Ca |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013906973 PECOS PAC ID: 3375456619 Enrollment ID: O20031111000892 |
News Archive
Officials announced Monday that the government will not enforce the mandate for businesses with 50 to 99 workers until 2016. In addition, larger employers will also be allowed to cover just 70 percent of workers in 2015, instead of the 90 percent originally required.
The Endocrine Society, representing more than 14,000 physicians and scientists in the field of endocrinology, strongly opposes the Medicare Payment Advisory Commission's (MedPAC) recommendation to reduce payments for specialists by 17.7 percent to partially fund the elimination of the sustainable growth rate (SGR) formula.
Researchers at the Mayo Clinic found they could isolate and culture nanoparticles from filtered homogenates of diseased calcified human cardiovascular tissue. These cultured nano-sized particles were recognized by a DNA-specific dye, incorporated radiolabeled uridine, and after decalcification, appeared via electron microscopy to contain cell walls.
Although drug therapy is the accepted first-line treatment for panic disorders, 17% to 64% of patients do not respond adequately and continue to exhibit one of the most common symptoms of PD, the panic attack.
A new tool for neuroscientists delivers a thousand pinpricks of light to a chunk of gray matter smaller than a sugar cube. The new fiber-optic device, created by biologists and engineers at the Massachusetts Institute of Technology (MIT) in Cambridge, is the first tool that can deliver precise points of light to a 3-D section of living brain tissue. The work is a step forward for a relatively new but promising technique that uses gene therapy to turn individual brain cells on and off with light.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Siba Prasad Raychaudhuri, MD 510 Ashton Ave, Palo Alto, CA 94306-3607 Ph: (650) 424-9147 | Dr Siba Prasad Raychaudhuri, MD 510 Ashton Ave, Palo Alto, CA 94306-3607 Ph: (650) 424-9147 |
News Archive
Officials announced Monday that the government will not enforce the mandate for businesses with 50 to 99 workers until 2016. In addition, larger employers will also be allowed to cover just 70 percent of workers in 2015, instead of the 90 percent originally required.
The Endocrine Society, representing more than 14,000 physicians and scientists in the field of endocrinology, strongly opposes the Medicare Payment Advisory Commission's (MedPAC) recommendation to reduce payments for specialists by 17.7 percent to partially fund the elimination of the sustainable growth rate (SGR) formula.
Researchers at the Mayo Clinic found they could isolate and culture nanoparticles from filtered homogenates of diseased calcified human cardiovascular tissue. These cultured nano-sized particles were recognized by a DNA-specific dye, incorporated radiolabeled uridine, and after decalcification, appeared via electron microscopy to contain cell walls.
Although drug therapy is the accepted first-line treatment for panic disorders, 17% to 64% of patients do not respond adequately and continue to exhibit one of the most common symptoms of PD, the panic attack.
A new tool for neuroscientists delivers a thousand pinpricks of light to a chunk of gray matter smaller than a sugar cube. The new fiber-optic device, created by biologists and engineers at the Massachusetts Institute of Technology (MIT) in Cambridge, is the first tool that can deliver precise points of light to a 3-D section of living brain tissue. The work is a step forward for a relatively new but promising technique that uses gene therapy to turn individual brain cells on and off with light.
› Verified 2 days ago
Daniel Joseph Razzano, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Mahnoosh Kuhbanani Seifoddini, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 3801 Miranda Ave, Va Palo Alto Health Care System (111stc), Palo Alto, CA 94304 Phone: 209-946-3400 | |
Dr. Yusra Nazar Hussain, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 770 Welch Rd, Suite # 250, Palo Alto, CA 94304 Phone: 650-328-1676 Fax: 650-445-0911 | |
Christopher Demuth Sharp, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 900 Blake Wilbur Dr, Palo Alto, CA 94304 Phone: 650-723-6028 Fax: 650-725-7078 | |
Dr. David Yao, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 3801 Miranda Ave, Medical Services (111a), Palo Alto, CA 94304 Phone: 650-493-5000 | |
Dr. Franklin Perry, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2175 Park Blvd, Palo Alto, CA 94306 Phone: 650-330-3688 Fax: 650-330-3686 | |
Dr. Ryan Arthur Mcconnell, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-853-2972 |